홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
Русский
English
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CLGN
#3898
CollPlant Biotechnologies Ltd Ordinary Shares
0.5
7
-1.72%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-1.72%
월간 변동
-70.62%
6달 변화
-79.86%
년간 변동율
-83.71%
이전 종가
0.5
8
Open
0.5
7
Bid
Ask
Low
0.5
7
High
0.5
7
양
1
마켓
주식
헬스케어
CLGN
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
11.45 M
44.87 M
Valuation ratios
Enterprise value
29.33 M
345.14 M
Price to earnings ratio
—
—
Price to sales ratio
—
—
Price to cash flow ratio
—
—
Price to book ratio
3.06
12.77
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
—
—
Return on equity %
—
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
4.29
37.03
Current ratio
4.44
38.21
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
—
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
1.04
7.17
Net current asset value per share
1.15
10.25
Tangible book value per share
1.16
10.29
Working capital per share
0.89
9.17
Book value per share
1.18
10.36
뉴스
CollPlant получила патент в Корее на технологию филлера
CollPlant secures Korean patent for dermal filler technology
CollPlant запускает набор биочернил BioFlex для 3D-биопечати
CollPlant launches BioFlex bioink kit for 3D bioprinting
D. Boral Capital понизил рейтинг акций CollPlant до "Держать"
CollPlant stock rating downgraded to Hold from Buy by D. Boral Capital
Рынок акций США закрылся падением, Dow Jones снизился на 1,20%
CollPlant Biotechnologies назначает годовое собрание на 31 декабря
CollPlant Biotechnologies schedules annual and extraordinary meeting for December 31
Collplant ADR: доходы, прибыль оказались ниже прогнозов в Q3
Collplant ADR earnings missed by $0.41, revenue fell short of estimates
Акции CollPlant снижаются из-за недостаточной выручки в Q3